Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
4:10 PM, Oct 06, 2017  |  BioCentury | Finance

Coasting on catalysts

is Phase II data from Regeneron Pharmaceuticals Inc. 's trials of nesvacumab, a mAb against angiopoietin 2
ANG2 ; ANGPT2), in combination with Eylea aflibercept to treat wet age-related macular degeneration (AMD …